 aprotinin reduc intraop postop blood loss membran oxygen cardiopulmonari bypass aprotinin signific improv hemostasi cardiopulmonari bypass membran oxygen drug prospect double-blind placebo-control clinic trial subject male patient cardiopulmonari bypass coronari arteri bypass graft forti patient aprotinin patient placebo control aprotinin kiu continu infus oper cardiopulmonari bypass kiu aprotinin pump prime intraop postop bleed third third total periop blood loss aprotinin-tr group total averag periop blood loss hemoglobin concentr mmol/l mL aprotinin-tr patient mL control patient reduct blood loss amount postop blood transfus percentag patient postop donor blood aprotinin activ clot time cardiopulmonari bypass reduct heparin usag improv hemostasi oper prolong clot time need heparin convers protamin end cardiopulmonari bypass retransfus cardiotomi suction blood vacuum suction